RTP-003B

N/A

Report date: 2023/01/03 14:48:16
NME

Base Information

Drug NameRTP-003B
Drug Alias NameRTP-003B
ClassificationSmall molecules
Mechanisms of ActionAmyloid protein aggregation inhibitorsAnti-oxidative stress
TargetsAmyloid
Therapy Area/IndicationsPresbyopiaCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Ruitong Biotechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Ruitong Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsPresbyopiaCataract
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A